These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 15665389)
1. Measurement reproducibility in the early stages of biomarker development. Liggett WS; Barker PE; Semmes OJ; Cazares LH Dis Markers; 2004; 20(6):295-307. PubMed ID: 15665389 [TBL] [Abstract][Full Text] [Related]
2. Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS). Hong H; Dragan Y; Epstein J; Teitel C; Chen B; Xie Q; Fang H; Shi L; Perkins R; Tong W BMC Bioinformatics; 2005 Jul; 6 Suppl 2(Suppl 2):S5. PubMed ID: 16026602 [TBL] [Abstract][Full Text] [Related]
3. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596 [TBL] [Abstract][Full Text] [Related]
4. SELDI-TOF serum proteomics and colorectal cancer: a current overview. Gemoll T; Roblick UJ; Auer G; Jörnvall H; Habermann JK Arch Physiol Biochem; 2010; 116(4-5):188-96. PubMed ID: 20615064 [TBL] [Abstract][Full Text] [Related]
5. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry. Liu XP; Shen J; Li ZF; Yan L; Gu J Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557 [TBL] [Abstract][Full Text] [Related]
6. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS). O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431 [TBL] [Abstract][Full Text] [Related]
7. Identification of the SELDI ProteinChip human serum retentate by microcapillary liquid chromatography-tandem mass spectrometry. Zhou M; Prieto DA; Lucas DA; Chan KC; Issaq HJ; Veenstra TD; Conrads TP J Proteome Res; 2006 Sep; 5(9):2207-16. PubMed ID: 16944932 [TBL] [Abstract][Full Text] [Related]
8. Advances in clinical cancer proteomics: SELDI-ToF-mass spectrometry and biomarker discovery. Seibert V; Ebert MP; Buschmann T Brief Funct Genomic Proteomic; 2005 May; 4(1):16-26. PubMed ID: 15975261 [TBL] [Abstract][Full Text] [Related]
9. Effects of pretreatment protocols on human amniotic fluid protein profiling with SELDI-TOF MS using protein chips and magnetic beads. Deng B; Dong Z; Liu Y; Wang C; Liu J; Wang C; Qu X Clin Chim Acta; 2010 Aug; 411(15-16):1051-7. PubMed ID: 20361951 [TBL] [Abstract][Full Text] [Related]
10. Application of serum SELDI proteomic patterns in diagnosis of lung cancer. Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516 [TBL] [Abstract][Full Text] [Related]
11. [Application of an integrated omics analysis for the discovery of biomarkers for osteosarcoma]. Li GD; Cai ZD; Ma XJ; Sun MX; Li J Zhonghua Yi Xue Za Zhi; 2012 Jan; 92(3):192-6. PubMed ID: 22490743 [TBL] [Abstract][Full Text] [Related]
12. Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry: multi-institution correlation of spectra and identification of biomarkers. Rai AJ; Stemmer PM; Zhang Z; Adam BL; Morgan WT; Caffrey RE; Podust VN; Patel M; Lim LY; Shipulina NV; Chan DW; Semmes OJ; Leung HC Proteomics; 2005 Aug; 5(13):3467-74. PubMed ID: 16052624 [TBL] [Abstract][Full Text] [Related]
13. Quality control and peak finding for proteomics data collected from nipple aspirate fluid by surface-enhanced laser desorption and ionization. Coombes KR; Fritsche HA; Clarke C; Chen JN; Baggerly KA; Morris JS; Xiao LC; Hung MC; Kuerer HM Clin Chem; 2003 Oct; 49(10):1615-23. PubMed ID: 14500586 [TBL] [Abstract][Full Text] [Related]
15. Protein profiling for cancer biomarker discovery using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and infrared imaging: a review. Bakry R; Rainer M; Huck CW; Bonn GK Anal Chim Acta; 2011 Mar; 690(1):26-34. PubMed ID: 21414433 [TBL] [Abstract][Full Text] [Related]
16. Proteomic Protocol in Esophageal Adenocarcinoma. Kelly P Methods Mol Biol; 2018; 1756():281-293. PubMed ID: 29600378 [TBL] [Abstract][Full Text] [Related]
17. SELDI-TOF-MS of saliva: methodology and pre-treatment effects. Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117 [TBL] [Abstract][Full Text] [Related]
18. [Proteomic analysis of prostate cancer using surface enhanced laser desorption/ionization mass spectrometry]. Pan YZ; Xiao XY; Zhao D; Zhang L; Ji GY; Li Y; He DC; Zhao XJ; Yang BX Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3172-5. PubMed ID: 16405834 [TBL] [Abstract][Full Text] [Related]
19. Use of surface enhanced laser desorption/ionization-time of flight mass spectrometry (SELDI-TOF MS) to study protein expression in a rat model of cocaine withdrawal. Geng T; Seitz PK; Thomas ML; Xu B; Soman KV; Kurosky A; Luxon BA; Cunningham KA J Neurosci Methods; 2006 Nov; 158(1):1-12. PubMed ID: 16766040 [TBL] [Abstract][Full Text] [Related]
20. Saliva analysis by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF/MS): from sample collection to data analysis. Papale M; Pedicillo MC; Di Paolo S; Thatcher BJ; Lo Muzio L; Bufo P; Rocchetti MT; Centra M; Ranieri E; Gesualdo L Clin Chem Lab Med; 2008; 46(1):89-99. PubMed ID: 18020972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]